First%20Trimester%20Screening - PowerPoint PPT Presentation

About This Presentation
Title:

First%20Trimester%20Screening

Description:

... 4.5% false positive Also associated with CHD, skeletal abnormalities, and diaphragmatic hernia Measurements must be performed by certified individual! – PowerPoint PPT presentation

Number of Views:739
Avg rating:3.0/5.0
Slides: 19
Provided by: UAMS
Learn more at: https://idhi.uams.edu
Category:

less

Transcript and Presenter's Notes

Title: First%20Trimester%20Screening


1
First Trimester Screening
Shannon N. Barringer, MS, CGC Chairman,
Department of Genetic Counseling UAMS, College of
Health Related Professions
2
Prenatal Screening History
Down Syndrome AFP Only
1st ? Free Beta
1st ? Biochem/NT
ONTD Screening
Maximizing 1st ? Screening
NT
hCG
Free Beta hCG
1st ? Papp-A
NB
1975 80 85 90 95 2000 2004
3
First Trimester Screening On the Horizon
  • GOALS of this screen
  • To increase sensitivity, decrease false-positive
    rates
  • To decrease number of unnecessary invasive
    prenatal diagnosis tests.
  • NOT to increase number of elective abortions.
  • U/S measurements (NT) and free B-hCG, PAPP-A

4
First Trimester Screening
  • A method to identify women at risk for having an
    aneuploid fetus from the general population
  • Also can identify other birth defects such as
    congenital heart defects and diaphragmatic hernia
  • Performed during 11-14 weeks gestation
  • Patient Preferences and earlier diagnosis/
    reassurance

5
Markers in Pregnancy
6
Nuchal Translucency
  • gt 3mm 30 risk of aneuploidy
  • 50-85 detection, 4.5 false positive
  • Also associated with CHD, skeletal abnormalities,
    and diaphragmatic hernia

Measurements must be performed by certified
individual!
7
Nuchal Translucency
Figure 10  Nuchal translucency measurement in 326
trisomy 21 fetuses plotted on the normal range
for crownrump length (95th and 5th centiles).
FMF, 2003.
8
Increased NT with Normal Chromosomes
  • Good chance of healthy baby
  • 90 with NTlt 4.5 mm
  • 80 with NT between 4.5 to 6.4 mm
  • 45 with NT gt6.5 mm
  • 20-30 have adverse pregnancy outcome
  • IUFD, PTD, low birth weight
  • Genetic syndromes, skeletal dysplasias, CHD
  • Risk appears to be proportionate to aneuploid
    risk
  • Still provide 18-20 week U/S and echocardiogram

9
PAPP-A and Free B-hCG
  • 60-68 detection of DS
  • 90 detection of Tri 18
  • 4.5 false positive rate
  • Also drawn at 11-14 weeks
  • Some centers quote 87 detection of DS when
    combined with maternal age
  • If both PAPP-A and B-hCG are very low MoM
    Increased risk for tri 18, triploidy, fetal
    anomalies or perinatal complications

10
PAPP-A and Free B-hCG
On average, baby with trisomy 21 will have 2.0
Mom for B-hCG and 0.4 MoM PAPP-A
11
NT, PAPP-A, and B-hCG
  • Krantz, et al (1999)
  • Women lt 35 years
  • 87.5 detection DS, 4.5 false positive
  • 100 detection Tri 18, 0.4 false positive
  • Women 35 years or older
  • 92 detection of DS, 14.3 false positive
  • 100 detection Tri 18, 1.4 false positive

12
Detection Rates-Fetal Down Syndrome
Marker
Timing
Detection Rate
AFP ALONE gt 15 weeks 20
AFP hCG gt15 weeks 60
AFP,hCG,uE3 gt15 weeks 65-70
AFP,hCG,uE3,DIA gt15 weeks 70-75
NT 11-14 weeks 70-80
NT, B-hCG, PAPP-A 11-14 weeks gt85
13
Other Markers and Screening?
  • Nasal Bone????
  • Fetal Cells in Maternal Circulation
  • Integrated Screening

14
Screening Protocol
15
Advantages of 1st Trimester Screening
  • Information earlier, more options
  • Reduce number of invasive procedures
  • May identify other severe anomalies (or risk for)
    at time of scan and increased risk of adverse
    pregnancy outcomereferral for 2nd ? evals.
  • Good time to date pregnancy accurately
  • NT good for multiple gestation

16
Limitations of First Trimester Screening
  • Accuracy of NT strongly dependant on experience
    of ultrasonographers
  • Not all women enter prenatal care in time for
    screening
  • Results of screen may arrive too late for CVS or
    early amnio
  • Extra cost for first trimester ultrasound
  • Can not detect NTD or AWD, still need MSAFP

17
Genetic Counseling
  • Nondirective counseling is vital
  • Informed consent is vital
  • The patient should undergo detailed counseling
    regarding first versus second trimester screening
  • All diagnostic testing options should be
    discussed

18
ACOG
  • Screening program must meet specific criteria
  • Trained, certified, monitored sonographers
    perform NT
  • NT alone is not sufficient, biochemistry must be
    included
  • Comprehensive genetic counseling must be offered
  • Access to diagnostic testing if abnormal screen
    results
  • Rigorous continual evaluations
Write a Comment
User Comments (0)
About PowerShow.com